Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hirayama

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Journal of Pharmaceutical Sciences|August 1, 1985
Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrinK Uekama, T Imai, T Maeda, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1990
Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipineA Yoshida, M Yamamoto, T Itoh, et al.
Journal of Gastroenterology|August 19, 1999
Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbilsF Hirayama, S Takagi, E Iwao, et al.
The Journal of Pharmacy and Pharmacology|September 28, 2000
Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in ratsK Tokihiro, H Arima, S Tajiri, et al.
Pharmaceutical Research|February 1, 1993
Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterizationF Hirayama, M Kurihara, Y Horiuchi, et al.
Thrombosis and Haemostasis|May 6, 1998
Effect of a synthetic factor Xa inhibitor, YM-60828, on blood vessel patency in combination with a thrombolytic agent and on blood loss from the operation site in a rat model of arterial thrombosisT Kawasaki, K Sato, F Hirayama, et al.
Legal Medicine (Tokyo, Japan)|August 26, 2003
RHC/c genotyping based on polymorphism in the promoter region of the RHCE geneM Tanaka, N Yamashita, J Takahashi, et al.
European Journal of Pharmacology|July 8, 1998
Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in ratsK Sato, Y Taniuchi, T Kawasaki, et al.
Transfusion Medicine (Oxford, England)|January 7, 2011
Role of mitochondria in the maintenance of platelet function during in vitro storageT Hayashi, S Tanaka, Y Hori, et al.
Immunology|May 1, 1995
Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cellsD Z Shao, S Yamada, F Hirayama, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Journal of Pharmaceutical Sciences|August 1, 1985
Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrinK Uekama, T Imai, T Maeda, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1990
Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipineA Yoshida, M Yamamoto, T Itoh, et al.
Journal of Gastroenterology|August 19, 1999
Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbilsF Hirayama, S Takagi, E Iwao, et al.
The Journal of Pharmacy and Pharmacology|September 28, 2000
Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in ratsK Tokihiro, H Arima, S Tajiri, et al.
Pharmaceutical Research|February 1, 1993
Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterizationF Hirayama, M Kurihara, Y Horiuchi, et al.
Thrombosis and Haemostasis|May 6, 1998
Effect of a synthetic factor Xa inhibitor, YM-60828, on blood vessel patency in combination with a thrombolytic agent and on blood loss from the operation site in a rat model of arterial thrombosisT Kawasaki, K Sato, F Hirayama, et al.
Legal Medicine (Tokyo, Japan)|August 26, 2003
RHC/c genotyping based on polymorphism in the promoter region of the RHCE geneM Tanaka, N Yamashita, J Takahashi, et al.
European Journal of Pharmacology|July 8, 1998
Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in ratsK Sato, Y Taniuchi, T Kawasaki, et al.
Transfusion Medicine (Oxford, England)|January 7, 2011
Role of mitochondria in the maintenance of platelet function during in vitro storageT Hayashi, S Tanaka, Y Hori, et al.
Immunology|May 1, 1995
Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cellsD Z Shao, S Yamada, F Hirayama, et al.
Pageof 13